CANADA LIFE ASSURANCE Co - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 137 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2018. The put-call ratio across all filers is 2.25 and the average weighting 0.0%.

Quarter-by-quarter ownership
CANADA LIFE ASSURANCE Co ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q1 2022$8,000
-33.3%
11,2430.0%0.00%
Q4 2021$12,000
-42.9%
11,2430.0%0.00%
Q3 2021$21,000
-30.0%
11,2430.0%0.00%
Q2 2021$30,000
-25.0%
11,2430.0%0.00%
Q1 2021$40,000
+42.9%
11,2430.0%0.00%
Q4 2020$28,0000.0%11,2430.0%0.00%
Q3 2020$28,000
-24.3%
11,2430.0%0.00%
Q2 2020$37,000
+60.9%
11,243
+22.3%
0.00%
Q1 2020$23,000
-46.5%
9,1940.0%0.00%
Q4 2019$43,000
-58.3%
9,194
-47.9%
0.00%
Q2 2019$103,000
+51.5%
17,6440.0%0.00%
Q1 2019$68,000
+112.5%
17,6440.0%0.00%
Q4 2018$32,000
-42.9%
17,6440.0%0.00%
Q3 2018$56,000
+5.7%
17,6440.0%0.00%
Q2 2018$53,000
-23.2%
17,6440.0%0.00%
Q1 2018$69,000
-5.5%
17,6440.0%0.00%
Q4 2017$73,000
-33.0%
17,6440.0%0.00%
Q3 2017$109,0000.0%17,6440.0%0.00%
Q2 2017$109,000
-1.8%
17,6440.0%0.00%
Q1 2017$111,000
+16.8%
17,6440.0%0.00%
Q4 2016$95,000
-52.0%
17,644
-50.0%
0.00%
Q3 2016$198,000
+106.2%
35,288
+100.0%
0.00%
Q2 2016$96,000
-26.7%
17,6440.0%0.00%
Q1 2016$131,000
-10.9%
17,6440.0%0.00%
-100.0%
Q4 2015$147,000
+129.7%
17,644
+148.2%
0.00%
Q3 2015$64,000
-24.7%
7,1090.0%0.00%
Q2 2015$85,000
+23.2%
7,109
+10.0%
0.00%
Q1 2015$69,0006,4610.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q2 2018
NameSharesValueWeighting ↓
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 14,642,959$25,186,0003.76%
MSD Partners, L.P. 15,151,516$26,061,0002.11%
MSD Partners, L.P. 7,575,758$13,030,0001.05%
MAGNOLIA CAPITAL ADVISORS LLC 418,569$720,0000.61%
STEEL GROVE CAPITAL ADVISORS, LLC 1,080,000$1,858,0000.33%
EAM Investors, LLC 454,625$782,0000.17%
Allred Capital Management, LLC 158,000$271,0000.17%
Boxer Capital, LLC 1,500,000$2,580,0000.14%
GSA CAPITAL PARTNERS LLP 608,037$1,046,0000.14%
CHIRON CAPITAL MANAGEMENT, LLC 116,860$201,0000.14%
View complete list of ZIOPHARM ONCOLOGY INC shareholders